Agfa reorganizes media capacity

Article

Agfa-Gevaert Group is consolidating its x-ray film production facilities. The plan involves bringing all related U.S. x-ray film production activity to the company's Bushy Park, SC, facility and closing down

Agfa-Gevaert Group is consolidating its x-ray film production facilities. The plan involves bringing all related U.S. x-ray film production activity to the company's Bushy Park, SC, facility and closing down operations at its Brevard, NC, manufacturing facility by year's end. The action reflects a market shift from medical screen-film to dry hard-copy media and the need to realize worldwide manufacturing efficiencies. It also reflects the company's transition to more environmentally friendly products, according to Robert S. Pryor, president of Agfa HealthCare, Americas. The Brevard facility manufactures aqueous-coated medical x-ray film. North American product demand is shifting from that product to solvent-coated hard-copy media, Pryor said. To keep the Brevard facility in tune with North American customer demands, the company would have to invest in solvent-coating capability, which Pryor described as "financially unattractive." Instead, the company can structure operations in Bushy Park to support North American customers' demand for high-quality diagnostic x-ray film, along with other film and media products. The consolidation is part of a larger, global efficiency initiative that began last year. Facilities in Germany, Belgium, Spain, and the U.K. have also been affected.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.